🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Let’s go back to basics... What is P-15? P-15 Peptide provides a distinct and proven mechanism of action, to attach and activate osteogenic cells to accelerate new bone formation. Learn more: hubs.ly/Q03qS1LY0 #P15PeptidePower #Cerapedics #RepairingBonesHealingLives

So many bone grafting options, so little high-quality evidence. How do you choose? FUSE (Fusion University for Surgical Excellence) was built to help. Created by Cerapedics Medical Education, FUSE is an interactive, surgeon-focused forum designed to cut through the noise —

Repairing bones. Healing lives. Cerapedics is a global orthopedics company dedicated to redefining the path to bone repair by healing bones faster and at higher rates, so patients can get back to living their fullest lives. hubs.ly/Q03rG67N0

Let's take a look at bone repair by the numbers.

Visit us at Mazama Spine Summit from June 20th-22nd in Winthrop, Washington where Roland Kent, MD, will present “Enhancing Clinical Outcomes in High-Risk Patients: An Evidence-Based Approach for the Selection of Bone Grafts.”, on June 21st. Download the invite.

Level 1, premarket approval (PMA), investigational device exemption (IDE) human clinical studies are essential for validating the safety and performance of advanced drug-device combination bone grafts, providing robust data to facilitate evidence-based decisions. Learn more

Today we announced US FDA approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, the first and only bone growth accelerator designed to accelerate lumbar fusion. With this approval, Cerapedics has two of only three spinal bone graft products that meet robust FDA evidence

Visit us at State of Spine Think Tank from June 26th-28th, in San Jose del Cabo, Mexico where Isaac L. Moss MDCM, Professor and Chair Department of Orthopaedic Surgery, UConn Health will present “Introducing PearlMatrix P-15 Peptide Enhanced Bone Graft: Data from the ASPIRE

For spinal bone grafts, the rigor of evidence required differs by US FDA regulatory pathway. Understanding how these evaluations vary is critical for making confident, informed decisions that impact patient outcomes. Learn more: hubs.ly/Q03v17gC0

It was great to connect with colleagues at State Of Spine Surgery Think Tank and hear Dr. Isaac Moss introduce the NOW US APPROVED PearlMatrix P-15 Peptide Enhanced Bone Graft. Did you attend? What was your biggest takeaway? Drop it in the comments 👇

Fusion takes time. ACCELERATE IT. PearlMatrix™ P-15 Peptide Enhanced Bone Graft is the first and only bone growth accelerator designed to accelerate lumbar fusion. Watch to learn how to close the surgery-to-fusion time gap. To learn more, visit hubs.ly/Q03vk9v20

Happy Fourth of July from Cerapedics!

Visit us at KASS from July 10th-12th in Huntington Beach, CA where Jeff Marx PhD, will present “Introducing PearlMatrix P-15 Peptide Enhanced Bone Graft: Data from the ASPIRE Trial”, on July 11th. Download the invite. hubs.ly/Q03vkyln0

We’re proud to announce that the first U.S. patient has been treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval. bit.ly/4eDXdrj This landmark procedure was performed in Colorado by Dr. Sharad Rajpal at AdventHealth Avista.

Cerapedics is a global orthopedics company dedicated to redefining the path to bone repair by healing bones faster and at higher rates, so all patients can get back to living their fullest lives. hubs.ly/Q03vKMPV0

It was great to connect with colleagues at the KASS Annual Meeting and hear Jeff Marx introduce the new PearlMatrix™ P-15 Peptide Enhanced Bone Graft. Did you attend? What was your biggest takeaway? Drop it in the comments 👇 #Cerapedics #PearlMatrix #P15PeptidePower

Spinal fusion surgeries are becoming more complex. Choose i-FACTOR. The first spinal bone graft powered by P-15 peptide backed by rigorous Level 1 human clinical data that included 28.5% high-risk patients. Indications for Use i-FACTOR is indicated for single level ACDF in

Fusion takes time. ACCELERATE IT. PearlMatrix™ P-15 Peptide Enhanced Bone Graft is the first and only bone growth accelerator designed to accelerate lumbar fusion. Watch to learn how to close the surgery-to-fusion time gap. To learn more, visit hubs.ly/Q03xmGtV0

The first and only bone growth accelerator proven to accelerate lumbar fusion.* To learn more, visit Cerapedics.com/products/Pearl… *Demonstrated statistically superior time-to-fusion in a single-level TLIF PMA IDE study vs. local autograft. This information is intended solely for

Calling all Spine Surgeons! Elevate Your Approach to Bone Graft Selection. Join us September 5-6 in Austin for FUSE, an exclusive, interactive medical education course designed to deepen your understanding of bone graft selection and fusion optimization. Enhance your clinical